疏肝健脾散结汤联合肝动脉插管化疗栓塞术治疗原发性肝癌疗效研究

目的:探讨疏肝健脾散结汤联合肝动脉插管化疗栓塞术对原发性肝癌的治疗效果.方法:选取原发性肝癌患者80例,按照随机数字表法分为对照组、观察组,各40例.对照组在肝动脉插管化疗栓塞术后行常规西医疗法,观察组在对照组基础上应用疏肝健脾散结汤.比较两组患者总缓解率、中医证候积分、肝功能和免疫功能.结果:观察组总缓解率为55.0...

Effect of Shugan Jianpi Sanjie decoction combined with transcatheter arterial chemoembolization in the treatment of primary liver cancer

Objective:To investigate effect of Shugan Jianpi Sanjie decoction combined with transcatheter arterial chemoembolization(TACE)for primary liver cancer.Methods:80 patients with primary liver cancer were selected and divided into control group and observation group,40 cases in each group,according to random number table method.The control group received conventional western medicine treatment after TACE,and the observation group received Shugan Jianpi Sanjie decoction on the basis of the control group.The total remission rate,TCM syndrome score,liver function and immune function were compared between the two groups.Results:The total remission rate of observation group was 55.00% higher than 32.50% of the control group.The TCM syndrome score of the observation group was(8.10±1.42)points lower than that of the control group(12.92±2.16)points,difference statistically significant(P<0.05).Before treatment,there was no significant difference in liver function and immune function between the two groups(all P>0.05).After treatment,the levels of aspartic aminotransferase,alanine aminotransferase,alpha-foetal protein,immunoglobulin A and immunoglobulin G in the observation group were lower than those in the control group,while the levels of natural killer cells and CD₄⁺ were higher than those in the control group,with statistical significance(all P<0.05).Conclusion:Patients with primary liver cancer received transcatheter arterial chemoembolization combined with Shugan Jianpi Sanjie decoction,clinical effect is better,and can relieve the clinical symptoms of patients,the improvement of liver function and immune function is also better.